ArticlePatient preference and adherence2026
Beyond Survival: Psychological Burden Impairs Medication Adherence in Chinese Patients with Chronic Myeloid Leukemia on TKI Therapy.
Article in Patient preference and adherence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Increasing research has linked mental health to reduced adherence in chronic diseases, yet this interplay remains insufficiently explored in chronic myeloid leukemia (CML). Methods: We conducted a cross-sectional online survey to analyze the critical role of non-treatment factors among Chinese CML patients receiving tyrosine kinase inhibitor (TKI) therapy. Anxiety and depression were assessed with the GAD-7/PHQ-9, quality of life (QoL) with the SF-12. Medication adherence was assessed using the Medication Possession Ratio (MPR), calculated as the percentage of actual medication possession days relative to the theoretical medication possession days. Binary logistic regression was used to identify factors associated with psychological burden and adherence. Results: Of 486 patients included, 52.5% reported anxiety (mild: 45.3%; moderate-severe: 7.2%) and 40.5% reported depression (mild: 29.8%; moderate-severe: 10.7%). QoL was impaired in both physical and mental domains (mean SF-12 PCS 46.22; MCS 45.62). Employment status and higher SF-12 PCS scores were significantly associated with lower psychological burden. Compared with patients reporting medium or high adherence, those with low adherence had higher rates of anxiety (20.2% vs 3.5% and 3.3%, P < 0.001) and depression (17.4% vs 8.8% and 8.7%, P=0.007) and lower MCS scores (43.72 vs 46.45 and 45.75, P=0.021). Binary logistic regression analysis showed that therapy duration, line of treatment, and psychological burden were significantly associated with adherence, patients with elevated psychological burden had 76.0% lower adherence odds (OR=0.24; 95% CI: 0.13-0.44; P<0.001), the strongest influencing factor. Conclusion: Psychological burden is the strongest determinant of impaired medication adherence in Chinese patients with CML on TKI therapy. Interventions that reduce psychological burden, particularly by promoting social-role participation and improving perceptions of physical health, may offer a new dimension for optimizing long-term outcomes in CML.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.